TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways.
Pseudomonas aeruginosa is a major cause of blindness and visual impairment in the United States and worldwide. Using a murine model of keratitis in which abraded corneas are infected with P. aeruginosa parent and ΔfliC (aflagellar) strains 19660 and PAO1, we found that F4/80(+) macrophages were the predominant cell type in the cornea expressing TLR2, TLR4, and TLR5. Depletion of macrophages and dendritic cells using transgenic Mafia mice, in which Fas ligand is selectively activated in these cells, resulted in diminished cytokine production and cellular infiltration to the corneal stroma and unimpaired bacterial growth. TLR4(-/-) mice showed a similar phenotype postinfection with ΔfliC strains, whereas TLR4/5(-/-) mice were susceptible to corneal infection with parent strains. Bone marrow-derived macrophages stimulated with ΔfliC bacteria induced Toll/IL-1R intracellular domain (TIR)-containing adaptor inducing IFN-β (TRIF)-dependent phosphorylation of IFN regulatory factor 3 in addition to TIR-containing adaptor protein/MyD88-dependent phosphorylation of IκB and nuclear translocation of the p65 subunit of NFκB. Furthermore, TRIF(-/-) mice showed a similar phenotype as TLR4(-/-) mice in regulating only ΔfliC bacteria, whereas MyD88(-/-) mice were unable to clear parent or ΔfliC bacteria. Finally, IL-1R1(-/-) and IL-1α/β(-/-) mice were highly susceptible to infection. Taken together, these findings indicate that P. aeruginosa activates TLR4/5 on resident corneal macrophages, which signal through TRIF and TIR-containing adaptor protein/MyD88 pathways, leading to NF-κB translocation to the nucleus, transcription of CXCL1 and other CXC chemokines, recruitment of neutrophils to the corneal stroma, and subsequent bacterial killing and tissue damage. IL-1α and IL-1β are also produced, which activate an IL-1R1/MyD88-positive feedback loop in macrophages and IL-1R on other resident cells in the cornea.
Sun
Yan
Y
Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
Karmakar
Mausita
M
Roy
Sanhita
S
Ramadan
Raniyah T
RT
Williams
Susan R
SR
Howell
Scott
S
Shive
Carey L
CL
Han
Yiping
Y
Stopford
Charles M
CM
Rietsch
Arne
A
Pearlman
Eric
E
D033942:Adaptor Proteins, Vesicular Transport / Q000276:immunology / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002469:Cell Separation; D003315:Cornea / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D004195:Disease Models, Animal; D005434:Flow Cytometry; D007150:Immunohistochemistry; D007634:Keratitis / Q000276:immunology* / Q000382:microbiology; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018613:Microscopy, Confocal; D053594:Myeloid Differentiation Factor 88 / Q000276:immunology* / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000276:immunology* / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000276:immunology* / Q000378:metabolism; D051198:Toll-Like Receptor 5 / Q000276:immunology* / Q000378:metabolism
D033942:Adaptor Proteins, Vesicular Transport; D053594:Myeloid Differentiation Factor 88; D051197:Toll-Like Receptor 4; D051198:Toll-Like Receptor 5; C507780:Myd88 protein, mouse; C476286:Ticam1 protein, mouse; C493487:Tlr4 protein, mouse
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):241-8
16384969
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1000-9
18326723
Nat Immunol. 2001 Sep;2(9):835-41
11526399
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1247-54
18936141
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4910-6
17065506
Prog Retin Eye Res. 2004 Jan;23(1):1-30
14766315
Nature. 2002 Nov 21;420(6913):329-33
12447442
Ocul Surf. 2008 Jul;6(3):108-16
18781257
Nat Rev Immunol. 2006 Mar;6(3):173-82
16498448
J Immunol. 2004 Sep 1;173(5):3337-47
15322197
Exp Eye Res. 2007 Dec;85(6):799-805
17905228
J Immunol. 2008 Jul 1;181(1):586-92
18566425
Clin Ophthalmol. 2008;2(4):907-917
19277209
J Immunol. 2009 Feb 1;182(3):1609-16
19155510
Eur J Immunol. 2007 Nov;37(11):3030-9
17935074
J Leukoc Biol. 2007 Mar;81(3):786-92
17110418
Cell. 2007 Sep 7;130(5):906-17
17803912
Curr Eye Res. 2007 Jul-Aug;32(7-8):595-609
17852183
Infect Immun. 2008 Jan;76(1):89-96
17938214
Nat Rev Immunol. 2007 May;7(5):353-64
17457343
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5220-7
14638720
J Immunol. 2003 May 15;170(10):5219-27
12734370
J Immunol. 2007 Mar 1;178(5):3170-6
17312165
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3100-6
20130275
J Exp Med. 2003 Oct 6;198(7):1043-55
14517278
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1568-74
17389486
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3892-8
12939306
Nat Immunol. 2010 May;11(5):373-84
20404851
Curr Eye Res. 1998 Jul;17(7):730-5
9678419
J Immunol. 2009 Mar 1;182(5):2738-44
19234168
J Immunol. 2009 Nov 15;183(10):6629-38
19846873
J Med Microbiol. 2008 Dec;57(Pt 12):1539-1546
19018027
J Exp Med. 2007 Dec 24;204(13):3235-45
18070936
Nature. 2001 Sep 6;413(6851):78-83
11544529
Gene. 1997 Feb 20;186(1):29-35
9047341
J Leukoc Biol. 2003 Aug;74(2):172-8
12885933
PLoS One. 2009 Oct 06;4(10):e7259
19806220
J Surg Res. 2006 Apr;131(2):296-301
16289593
Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L312-22
16936244
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12487-92
16891416
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2264-71
12091426
J Leukoc Biol. 2004 Apr;75(4):612-23
14726498
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1255-63
16565355
Cell. 2006 Jun 2;125(5):943-55
16751103
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4664-70
17898290
Am J Respir Cell Mol Biol. 2005 Nov;33(5):470-5
16100080
Proc Natl Acad Sci U S A. 2005 May 31;102(22):8006-11
15911752
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):589-95
15671286
Stem Cells. 2005 Apr;23(4):507-15
15790772
J Immunol. 2005 Dec 1;175(11):7484-95
16301656
J Immunol. 2006 Jul 1;177(1):538-47
16785551
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):497-503
15671274
Cornea. 2008 Jan;27(1):22-7
18245962
J Immunol. 2007 Mar 1;178(5):3153-60
17312163
Curr Eye Res. 2004 Oct-Nov;29(4-5):225-33
15590467
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):805-10
10711697
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4247-54
14507868
J Biol Chem. 2008 Feb 15;283(7):3988-96
18057004
J Leukoc Biol. 2008 Apr;83(4):991-7
18218857
Cytokine. 2008 Sep;43(3):342-9
18706831
Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2867-77
11687531
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2278-84
12091428
J Immunol. 2000 Jun 15;164(12):6576-82
10843717
PLoS Pathog. 2010 Mar 26;6(3):e1000826
20361053
Physiol Genomics. 2004 Nov 17;19(3):319-30
15367722